Aanwerving proef = ; Lopend onderzoek = ; Terminated trial = ; Gefinancierd door een IRDiRC-lid = ; Lid van een ERN =

Nationale klinische studie(s)

BELGIË

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Calciphyx: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis - BE

Erasme Hospital - ULB

Néphrologie

Meer details

DUITSLAND

Hamburg
HAMBURG

Calciphyx: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis - DE

DaVita Deutschland AG

Meer details

FRANKRIJK

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis -FR

Institution: Information not provided - FR

Meer details

SPANJE

Madrid
ADDRESS: NOT PROVIDED - ES

Calciphyx: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis - ES (completed)

Institution: Information not provided - ES

Meer details